rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2007-3-8
|
pubmed:abstractText |
Natriuretic peptides are important in the maintenance of body volume homeostasis. There has been interest in utilizing the levels of these peptides to diagnose and prognosticate cardiovascular disease. In end-stage renal disease, the diagnostic utility of these peptides is limited. Madsen et al. report that levels of N-terminal pro brain natriuretic peptide (NT-proBNP) levels offer important information on the risk of mortality in patients undergoing hemodialysis.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0085-2538
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
481-3
|
pubmed:meshHeading |
pubmed-meshheading:17344896-Cardiovascular Diseases,
pubmed-meshheading:17344896-Homeostasis,
pubmed-meshheading:17344896-Humans,
pubmed-meshheading:17344896-Kidney Failure, Chronic,
pubmed-meshheading:17344896-Natriuretic Peptide, Brain,
pubmed-meshheading:17344896-Peptide Fragments,
pubmed-meshheading:17344896-Predictive Value of Tests,
pubmed-meshheading:17344896-Prognosis,
pubmed-meshheading:17344896-Regression Analysis,
pubmed-meshheading:17344896-Renal Dialysis,
pubmed-meshheading:17344896-Risk Factors,
pubmed-meshheading:17344896-Ventricular Dysfunction, Left
|
pubmed:year |
2007
|
pubmed:articleTitle |
Measuring risk in end-stage renal disease: is N-terminal pro brain natriuretic peptide a useful marker?
|
pubmed:affiliation |
Division of Nephrology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia 22908, USA. mhr9r@virginia.edu
|
pubmed:publicationType |
Journal Article,
Comment
|